Invest in a patented and Health Ministry approved technology that is already being used in hospitals for detection of tumors as small as one millimeterThe Business
The Company has developed a non-invasive device for early cancer detection. It has been patented and subsequently approved by the Italian Ministry of Health. It is already being used in some Italian hospitals. The device has the potential to dramatically change cancer prevention procedures by allowing the diagnosis of cancer tumors as small as one millimeter.
The device consists of a hand-held detector that emits a low power electromagnetic field. It generates a noninvasive tissue analysis that detects and diagnoses tumor formations. There is also a receiver that uses a dedicated software program to display the interaction of the hand-held detector with the tissue and records the results. The electromagnetic emission consists in the generation of three frequencies in the UHF band; each frequency is associated with a specific response generated from tissues of different types.
Market
The effectiveness of the device has been documented in numerous scientific publications and has been confirmed by the hospitals that use it on a daily basis to perform tests in agreement with the Italian National Health Service. The device is user and patient friendly – a hand-held device that is passed over the body similar to detectors used at airport security.
The inventor of the device has personally invested thousands of Euros to patent the product around the world. He is dissatisfied with the management of his invention and is therefore looking for serious investors worldwide. He aims to restart the production of the device and further improve its performance.
Sector: Health CareSegment: Medical DevicesRegion: EuropeFinancing Size: $5m to $20mContact: Saverio Canepa
Company: SIMI Telephone: +39 068 069 1423Email: [email protected]